The following is the transcript of the interview with Dr. Scott Gottlieb, former FDA commissioner, that aired on "Face the Nation with Margaret Brennan" on Feb. 8, 2026. Dr. Gottlieb also sits on the ...
Scott Gottlieb, MD, discusses the real-world outcomes of tildrakizumab for moderate to severe plaque psoriasis.
Add Yahoo as a preferred source to see more of our stories on Google. Former FDA Commissioner Dr. Scott Gottlieb, who sits on the boards of Pfizer and UnitedHealthcare, told "Face the Nation with ...
Hosted on MSN
Gottlieb says Hims & Hers risks DOJ action over unapproved GLP-1 rival to Novo Nordisk - CNBC interview
Scott Gottlieb, former FDA commissioner, says Hims & Hers (HIMS) could face serious regulatory consequences after the company attempted to sell an unapproved oral GLP-1 drug that mimicked Novo Nordisk ...
Add Yahoo as a preferred source to see more of our stories on Google. Missed the second half of the show? Rep. Tony Gonzales, Center for Election Innovation and Research Executive Director David ...
Scott Gottlieb, M.D., is a physician who served as the 23rd Commissioner of the U.S. Food and Drug Administration from 2017 to 2019. He is currently a senior fellow at the American Enterprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results